Global Semiconductor Investment Will Advance Photonics And Mobility Expansion

Key Takeaways

• Momentum in semiconductor, biophotonics, and mobility segments, combined with global expansion, diversifies revenue and positions for sustained long-term growth.
  
• Strategic shift to higher-margin photonic solutions and disciplined cost management are driving improved margins and elevated earnings quality.
  
• Exposure to volatile end-markets, margin compression, and tariff risks threaten revenue predictability, profitability, and delay sustainable recovery amid ongoing demand uncertainty.

Catalysts

Provides advanced photonic solutions and smart mobility solutions in Germany and internationally.

• Jenoptik is positioned to benefit from increasing global investment in semiconductor manufacturing (spurred by AI, automotive, and IoT demand), as order intake in its semi segment showed significant quarter-on-quarter improvement and customers are signaling readiness for capacity ramp, which, if sustained, would drive revenue and margin recovery over the next 12-18 months.
  
• Strong momentum in the Biophotonics segment, with robust order intake and double-digit revenue growth across key areas like dental, ophthalmology, and life science, demonstrates exposure to rising automation and digitalization needs in healthcare and diagnostics, supporting both top-line expansion and higher EBITDA margins.
  
• Jenoptik's Smart Mobility Solutions business is experiencing rapid growth, especially in the U.S. and Middle East, reflecting rising investment in smart infrastructure and intelligent traffic management; this contributes to diversified revenue streams and higher overall growth potential.
  
• Ongoing portfolio shift towards higher-margin, software-enabled photonic solutions, combined with disciplined cost and cash management (evidenced by a material increase in cash conversion rate and reduced headcount), is likely to support margin expansion and enhance earnings quality over the medium term.
  
• Expansion of production and customer presence in North America and Asia-as evidenced by growing business in U.S. markets and localized production capabilities-reduces concentration risk, improves resilience amid geopolitical volatility, and positions Jenoptik to capture more growth from global photonics adoption, supporting organic revenue growth longer-term.

Jenoptik Future Earnings and Revenue Growth

Assumptions

• Analysts are assuming Jenoptik's revenue will grow by 4.6% annually over the next 3 years.
• Analysts assume that profit margins will increase from 6.8% today to 9.5% in 3 years time.
• Analysts expect earnings to reach €116.8 million (and earnings per share of €2.0) by about September 2028, up from €73.2 million today. However, there is a considerable amount of disagreement amongst the analysts with the most bullish expecting €133.2 million in earnings, and the most bearish expecting €96.4 million.
• In order for the above numbers to justify the analysts price target, the company would need to trade at a PE ratio of 15.5x on those 2028 earnings, up from 12.9x today. This future PE is lower than the current PE for the GB Electronic industry at 34.0x.
• Analysts expect the number of shares outstanding to grow by 1.39% per year for the next 3 years.
• To value all of this in today's terms, we will use a discount rate of 6.96%, as per the Simply Wall St company report.

Jenoptik Future Earnings Per Share Growth

Risks

• Ongoing elevated market uncertainty and fragmented demand patterns across key segments (especially in semiconductors and metrology) create significant volatility in quarterly revenues, reducing visibility and predictability for long-term revenue growth.
  
• Persistent weakness in the semiconductor (Semi) division, which remains a major business driver and is exposed to supply chain disruptions, inventory cycles, and mixed customer messages, may continue to pressure both top-line revenue and margin recovery.
  
• Margin compression is evident, with year-on-year declines in gross margin (down 250 bps) and EBITDA margin (down 300 bps), primarily due to negative product mix effects, lower fixed-cost absorption, wage inflation, and tariff impacts, which are expected to persist and could further erode net margins if demand does not sustainably recover.
  
• Tariff uncertainty, especially regarding business with the U.S., poses both direct costs (estimated at 50 bps for the partial year, potentially higher if full-year impact materializes) and longer-term risks around competitive positioning, potentially undermining both revenue and profitability if Jenoptik faces cost disadvantages versus localized competitors.
  
• High reliance on cyclical and volatile end-markets (e.g., semiconductors, automotive, OEMs) and the lack of clear evidence for a sustained demand recovery expose Jenoptik to ongoing revenue swings and increase the risk of extended periods of underutilization, which may delay earnings recovery and strain free cash flow.

Valuation

• The analysts have a consensus price target of €25.122 for Jenoptik based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of €35.0, and the most bearish reporting a price target of just €18.5.
• In order for you to agree with the analyst's consensus, you'd need to believe that by 2028, revenues will be €1.2 billion, earnings will come to €116.8 million, and it would be trading on a PE ratio of 15.5x, assuming you use a discount rate of 7.0%.
• Given the current share price of €16.47, the analyst price target of €25.12 is 34.4% higher.
• We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.